Chargement en cours...
Immunomodulatory Drugs in the Management of SARS-CoV-2
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Frontiers Media S.A.
2020-08-01
|
Collection: | Frontiers in Immunology |
Sujets: | |
Accès en ligne: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01844/full |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|